Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.
 

Notice of Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Program Official
Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech NOT-NS-23-002 06/21/2024
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-23-314 (UH3 Clinical Trials Not Allowed) UH3 10/15/2026 Sudhir Srivastava, Ph.D., M.P.H.
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers NOT-CA-23-004 07/02/2025 Matthew Young, Ph.D.
Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer NOT-CA-22-085 05/08/2027 Sharon Ross, Ph.D., M.P.H.
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers PAR-23-288 (K99/R00 - Independent Basic Experimental Studies with Humans Required) R00, K99 10/15/2026 Jessica Faupel-Badger, Ph.D., M.P.H.
Notice of Special Interest (NOSI): Career Development Opportunities for Research Within the Mission of the Division of Cancer Prevention at the National Cancer Institute NOT-CA-23-035 11/13/2024 Jessica Faupel-Badger, Ph.D., M.P.H.
Notice of Special Interest (NOSI): Research on the Etiology, Early Detection, Screening and Prevention of Early-Onset Colorectal Cancer NOT-CA-23-018 09/08/2024
Mechanisms that Impact Cancer Risk after Bariatric Surgery PAR-21-332 (R21 Clinical Trial Not Allowed) R21 Clinical Trial Not Allowed 09/08/2024 Edward Sauter, M.D., Ph.D.
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research RFA-CA-24-008 (R61 Clinical Trial Not Allowed) R61 Clinical Trial Not Allowed 10/02/2024 Guillermo Marquez, Ph.D.
HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment RFA-NS-22-034 (R01 Clinical Trial Not Allowed) R01 Clinical Trial Not Allowed 12/07/2024 Rachel Altshuler, Ph.D.